Nutrition and Inflammation in Pregnancy: Impacts on Early Human Brain Development in Ethiopia

NCT06296238 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 463

Last updated 2025-03-26

No results posted yet for this study

Summary

The goal of this observational child follow-up study is to examine the effects of prenatal nutrition and infection management interventions on long-term child neurodevelopment.

Participants are the offspring of mothers in the main study entitled "Enhancing Nutrition and Antenatal Infection Treatment (ENAT)" that was conducted in the rural Amhara region of Ethiopia. In the ENAT pragmatic clinical effectiveness study, 2399 pregnant women were randomized to receive routine prenatal care, a package of enhanced nutrition interventions (balanced energy protein supplement, iodized salt, iron-folic acid and counseling), a package of enhanced infection management interventions (genitourinary tract infection screening-treatment, deworming), or a combination of both packages. The impact of these antenatal nutrition and infection interventions on birth outcomes (infant birth size and gestational length) was examined in the main study. In this longitudinal cohort study, we will follow the offspring from the ENAT pregnancy cohort up to 24 months postnatal age and assess their growth, health and neurodevelopment.

The main questions it aims to answer are:

1. What are the effects of pregnancy interventions from the parent study (ENAT) on offspring neurodevelopmental outcomes?
2. What are the associations between maternal-newborn iron status and inflammation on infant neurodevelopment?
3. What are the associations between maternal iodine status and thyroid function on infant neurodevelopment?

We will follow children of mothers from the parent ENAT study to monitor their growth, health, and neurodevelopment up to 24 months postnatal age.

Conditions

  • Prenatal Exposure Delayed Effects

Sponsors & Collaborators

  • Addis Continental Institute of Public Health

    collaborator OTHER
  • Boston Children's Hospital

    collaborator OTHER
  • New York University

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • Brown University

    lead OTHER

Principal Investigators

  • Yemane Berhane · Addis Continental Institute of Public Health

  • Anne CC Lee · Warren Alpert Medical School of Brown University

Eligibility

Min Age
9 Months
Max Age
27 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06296238 on ClinicalTrials.gov